Through the Mectizan Donation Program, Merck & Co., Inc. has donated Mectizan (ivermectin, MSD) for the treatment of onchocerciasis worldwide since 1987. Mectizan has also been donated for the elimination of lymphatic filariasis (LF) since 1998 in African countries and in Yemen where onchocerciasis and LF are co-endemic; for LF elimination programs, Mectizan is co-administered with albendazole,...

A meta-analysis was conducted to determine whether differences in efficacy exist among treatment approaches applied to youth. Included were all studies published between 1980 and 2005 involving participants 18 years of age or younger with diagnoses of depression, anxiety, conduct disorder, and attention-deficit/hyperactivity disorder that contained direct comparisons among two or more treatment...

purpose : to evaluate the role of orthoptic treatments in the management of intermittent exotropia methods : in a retrospective study, clinical records of patients diagnosed with intermittent exotropia were reviewed. patients with basic, convergence insufficiency (ci) and divergence excess (de) types of intermittent exotropia who underwent orthoptic treatments were enrolled. office treatments i...